PolitMaster.com is a comprehensive online platform providing insightful coverage of the political arena: International Relations, Domestic Policies, Economic Developments, Electoral Processes, and Legislative Updates. With expert analysis, live updates, and in-depth features, we bring you closer to the heart of politics. Exclusive interviews, up-to-date photos, and video content, alongside breaking news, keep you informed around the clock. Stay engaged with the world of politics 24/7.
Louisiana is set to be the first state in the US to criminalize possession of widely used abortion drugs, with a bill that has alarmed abortion rights advocates and doctors across the state and drawn warnings from the White House.
Despite the Supreme Court unanimously rejecting an attack on abortion pills this week, pro-choice advocates are cautioning against calling the decision a win — and for good reason.
Arkansas Attorney General Tim Griffin has sent cease-and-desist letters to two abortion pill providers in New York and Europe, demanding they stop marketing and selling the medication in his state, where abortion is illegal.
The Louisiana state House voted Tuesday to add two common medications used for abortions to the state’s list of controlled, dangerous substances despite widespread evidence they’re perfectly safe and effective.
New York Attorney General Letitia James (D) on Monday announced that the state is suing Heartbeat International, an anti-abortion group, for making what she says are misleading and “incredibly dangerous” claims about medication abortion.
Rep. Jasmine Crockett (D-Texas) mocked anti-abortion advocates’ argument to restrict access to the abortion pill mifepristone by making an example out of Viagra at a House Oversight Committee meeting on Thursday.
Access to abortion pills has dominated national headlines this week, as the Supreme Court heard a case that could roll back critical access to mifepristone , one of the two drugs used in medication abortion.
One moment in particular, during Tuesday’s arguments over the availability of the abortion drug mifepristone before the Supreme Court, may have gone unnoticed ― despite its crucial importance.